VanEck Pharmaceutical ETF
PPH
#1347
ETF rank
A$1.33 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
A$156.21
Share price
1.35%
Change (1 day)
19.30%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of July 2026: 0.36%

Net Expense Ratio

Net Expense Ratio as of July 2026: 0.36%